NCT05165082View on ClinicalTrials.gov

The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 21, 2021

Primary Completion Date

January 21, 2023

Study Completion Date

March 21, 2023

Conditions
ParonychiaEpidermal Growth Factor Receptor Inhibitor
Interventions
DRUG

Timolol maleate 0.5% ophthalmic solution

Apply on affected finger or toes twice daily for 8 weeks

PROCEDURE

Cryotherapy with liquid nitrogen

Conducted on affected finger or toes every other week for four sessions.

Trial Locations (1)

Unknown

Taipei Municipal Wan-Fang Hospital, Taipei

All Listed Sponsors
lead

Taipei Medical University WanFang Hospital

OTHER

NCT05165082 - The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study | Biotech Hunter | Biotech Hunter